DIABNEXT was founded with the vision of developing highly innovative solutions that help people with diabetes better manage their chronic condition and improve their care and quality of life. Through collaboration with many leaders and clinicians in diabetes healthcare, the DIABNEXT platform offers patients a unique solution that enables remote monitoring, coordination, therapeutic education and analytics of data related to blood glucose, insulin, diet and physical activity automatically through connected health devices. DIABNEXT was acquired by Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, in March 2022. The DIABNEXT platform is now marketed under the name Glooko XT.